Crinetics Pharmaceuticals

ISIN US22663K1079

 | 

WKN A2JQTJ

Market cap (in EUR)
7,700 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 7,700 m
EPS, EUR -4.33
P/B ratio 7.5
P/E ratio -
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 7 m
Net income, EUR -412 m
Profit margin -6,046.22%

What ETF is Crinetics Pharmaceuticals in?

There are 7 ETFs which contain Crinetics Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Crinetics Pharmaceuticals is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.62%
Equity
United States
Health Care
Biotech
72
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
554
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist 0.28%
Equity
United States
Small Cap
3
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
WisdomTree Russell 2000 0.28%
Equity
United States
Small Cap
7
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.12%
Equity
United States
Small Cap
230
Vanguard FTSE Global All-Cap UCITS ETF USD Dist 0.01%
Equity
World
9
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.